Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Nordt

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Zeitschrift Fur Kardiologie|June 21, 2016
[Therapeutic inhibition of platelets in acute coronary syndrome and in coronary intervention: mechanisms and clinical results]K Peter, T Nordt, C Bode
Zeitschrift Fur Kardiologie|December 1, 2000
[Therapeutic inhibition of platelets in a acute coronary syndrome and in coronary intervention: mechanisms and clinical results]K Peter, T Nordt, C Bode
Thrombosis Research|September 25, 2001
Intrinsic activating properties of GP IIb/IIIa blockersK Peter, M Schwarz, T Nordt, et al.
Cardiovascular Research|December 1, 1994
Stimulation of migration of human aortic smooth muscle cells by vitronectin: implications for atherosclerosisS L Brown, C H Lundgren, T Nordt, et al.
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|June 1, 1993
[Thrombolytic therapy of acute myocardial infarct--current status and new developments]C Bode, G Schuler, E von Hodenberg, et al.
Zeitschrift Fur Kardiologie|January 1, 1993
Combinations of thrombolytic agents in acute myocardial infarctionC Bode, H Baumann, E von Hodenberg, et al.
The American Journal of Cardiology|June 15, 1991
Effects of lipoprotein (a) on success rate of thrombolytic therapy in acute myocardial infarctionE von Hodenberg, J Kreuzer, M Hautmann, et al.
Circulation|October 6, 1999
Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18)K Peter, M Schwarz, C Conradt, et al.
Journal of Thrombosis and Haemostasis : JTH|April 22, 2004
Construction and characterization of a recombinant plasminogen activator composed of an anti-fibrin single-chain antibody and low-molecular-weight urokinaseC E Hagemeyer, I Tomic, U Weirich, et al.
Blood|October 27, 1998
Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitorsK Peter, M Schwarz, J Ylänne, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Zeitschrift Fur Kardiologie|June 21, 2016
[Therapeutic inhibition of platelets in acute coronary syndrome and in coronary intervention: mechanisms and clinical results]K Peter, T Nordt, C Bode
Zeitschrift Fur Kardiologie|December 1, 2000
[Therapeutic inhibition of platelets in a acute coronary syndrome and in coronary intervention: mechanisms and clinical results]K Peter, T Nordt, C Bode
Thrombosis Research|September 25, 2001
Intrinsic activating properties of GP IIb/IIIa blockersK Peter, M Schwarz, T Nordt, et al.
Cardiovascular Research|December 1, 1994
Stimulation of migration of human aortic smooth muscle cells by vitronectin: implications for atherosclerosisS L Brown, C H Lundgren, T Nordt, et al.
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|June 1, 1993
[Thrombolytic therapy of acute myocardial infarct--current status and new developments]C Bode, G Schuler, E von Hodenberg, et al.
Zeitschrift Fur Kardiologie|January 1, 1993
Combinations of thrombolytic agents in acute myocardial infarctionC Bode, H Baumann, E von Hodenberg, et al.
The American Journal of Cardiology|June 15, 1991
Effects of lipoprotein (a) on success rate of thrombolytic therapy in acute myocardial infarctionE von Hodenberg, J Kreuzer, M Hautmann, et al.
Circulation|October 6, 1999
Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18)K Peter, M Schwarz, C Conradt, et al.
Journal of Thrombosis and Haemostasis : JTH|April 22, 2004
Construction and characterization of a recombinant plasminogen activator composed of an anti-fibrin single-chain antibody and low-molecular-weight urokinaseC E Hagemeyer, I Tomic, U Weirich, et al.
Blood|October 27, 1998
Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitorsK Peter, M Schwarz, J Ylänne, et al.
Pageof 2